Rigel Pharmaceuticals reported $-26024000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acura Pharmaceuticals ACUR:US -282000 154K
Agenus AGEN:US $ -34.34M 20.08M
Amgen AMGN:US $ 3341M 185M
Anika Therapeutics ANIK:US $ 0.06M 5.22M
Applied Genetic Technologies AGTC:US $ -13.1M 4.79M
Arrowhead Research ARWR:US $ 44.15M 104.9M
Astrazeneca AZN:US $ 4187M 687M
AstraZeneca AZN:LN 4187M 687M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Bristol Myers Squibb BMY:US $ 5772M 404M
Celldex Therapeutics CLDX:US $ -22.45M 2.88M
Chemocentryx CCXI:US $ -37.22M 1.82M
Daiichi Sankyo 4568:JP Y -35701M 88958M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Immunogen IMGN:US $ -22.38M 11.71M
Intrexon XON:US $ -14.12M 3.05M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Ligand Pharmaceuticals LGND:US $ 4.35M 21.55M
Macrogenics MGNX:US $ -63725000 8.44M
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Pfizer PFE:US $ 11182M 4046M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Rigel Pharmaceuticals RIGL:US $ -26.02M 8.53M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
Veracyte VCYT:US $ -8.69M 6.56M